MB

MPM BioImpact Portfolio holdings

AUM $577M
1-Year Est. Return 8.33%
This Quarter Est. Return
1 Year Est. Return
+8.33%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$375M
AUM Growth
-$122M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
38
New
Increased
Reduced
Closed

Top Buys

1
+$17.2M
2
+$11.6M
3
+$9.11M
4
MORF
Morphic Holding, Inc. Common Stock
MORF
+$4.58M
5
VKTX icon
Viking Therapeutics
VKTX
+$3.6M

Top Sells

1
+$47.8M
2
+$38.6M
3
+$23.9M
4
EWTX icon
Edgewise Therapeutics
EWTX
+$5.52M
5
KALV icon
KalVista Pharmaceuticals
KALV
+$1.77M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$69.2M 18.48%
7,648,268
2
$22.9M 6.12%
1,857,681
+1,395,181
3
$22.7M 6.06%
10,712,481
+1,521,191
4
$19.8M 5.29%
1,639,849
5
$19.1M 5.1%
1,745,943
6
$17.2M 4.6%
544,639
7
$16.8M 4.48%
294,190
-921
8
$15M 3.99%
3,287,397
+337,279
9
$14.2M 3.8%
479,053
10
$13.3M 3.56%
527,458
-2,285
11
$11.6M 3.11%
+230,761
12
$11.4M 3.04%
857,940
13
$11.4M 3.04%
1,352,133
-2,235
14
$10.8M 2.89%
656,718
15
$9.11M 2.43%
+610,770
16
$9M 2.4%
53,210
-189
17
$8.71M 2.32%
716,139
+200,000
18
$7.57M 2.02%
273,408
19
$7.42M 1.98%
3,987,967
+12,968
20
$6.84M 1.83%
664,224
+279,234
21
$6.54M 1.75%
93,586
22
$5.97M 1.59%
40,859
+2,848
23
$5.57M 1.49%
577,958
-183,580
24
$5.11M 1.36%
2,388,011
25
$4.94M 1.32%
552,846
1
2